CaliPharms Operating Income

CaliPharms (KGET) currently reports a operating income of $-820K as of September 2014. That compares with $-110K in the prior-year period — down 662.4% year over year. Use the charts on this page to explore CaliPharms's operating income history and peer comparisons.

CaliPharms's operating income decreased from $-110K to $-820K — a 662.4% year-over-year decrease (period ending September 2014). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CaliPharms reported $-820K in operating income as of September 2014. That compares with $-110K in the prior-year period — down 662.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-820K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for CaliPharms, and consider following KGET for alerts when major investors trade the stock.

CaliPharms is classified in the Industrials sector. On operating income, it currently shows $-820K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Industrials are usually more informative than comparing KGET with unrelated industries.